US OptionsDetailed Quotes
LLY241206P1025000
- 0.00
- 0.000.00%
15min DelayClose Dec 2 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest1025.00Strike Price0.00Turnover0.00%IV-28.16%PremiumDec 6, 2024Expiry Date225.20Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Eli Lilly and Co Stock Discussion
Don’t Miss The Wave 🌊 🏄♂️
Historic 2 Weeks Nov 25-29 December 2-7
SMCI SMCX WHOA 🤯
• TOP TIER
BTC to $100K *
ETH to $4,000 *
NOW to $1041
LLY to $788.19
BRK.B to $483 *
MSFT to $423
PANW to $384.37
CRWD to $347.59
TSLA to $333 *
APP to $328.56
MDB to $324.6 *
PGR to $266.86
CVNA to $255 *
CEG to $253.39
FTEC to $183.43
ORCL to $182.7
TSM to $181.19
VST 154.52 160-200 soon 🔜
NVDA to $135 *
MSTX...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
"By issuing the proposal in its waning days, the Biden administration is leaving Trump health officials with the political dilemma of whether to go ahead with an expensive proposal popular with some supporters or to cancel plans while the administration pursues tax cuts."
Unquote:
I wonder if you read carefully. Musk wasn't wrong when he mentioned lazy posting lately. Trump health officials is the hhs who believed vax causes autism, not believe in germs, flouride, etc and the doge not do...
If you can't tell yet that something smells fishy for the timing of the WSJ news about Biden passing law for Medicare accepting fatloss drug on holiday week. Then you deserve what is going to happen next.
It’s unusual for a major policy like expanding Medicare and Medicaid to cover weight-loss drugs to be proposed 30 days before a presidential term ends. Such changes require legislative approval or regulatory adjustments, both of w...
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
Mark my word, if LLY close this week anyway below 745.26 it is done!
No comment yet